Live Leishmania promastigotes can directly activate primary human natural killer cells to produce interferon-gamma. (Q40668224)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605699%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Live Leishmania promastigotes can directly activate primary human natural killer cells to produce interferon-gamma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605699%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605699%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Hannah Akuffo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605699%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

K Maasho

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605699%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

K Söderstrom

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605699%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

T Ilg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605699%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605699%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605699%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605699%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605699%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

457-467

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605699%20AND%20SRC:MED&resulttype=core&format=json

Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02096.X

Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02096.X

Lipophosphoglycan is not required for infection of macrophages or mice by Leishmania mexicana

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02096.X

Phosphoglycan repeat-deficient Leishmania mexicana parasites remain infectious to macrophages and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02096.X

A new method for isolation of human lymphocyte subsets reveals differential regulation of beta-adrenergic receptors by terbutaline treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02096.X

T cell independent antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02096.X

Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02096.X

Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02096.X

IFN-alpha and IL-18 synergistically enhance IFN-gamma production in human NK cells: differential regulation of Stat4 activation and IFN-gamma gene expression by IFN-alpha and IL-12.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808651

Vaccination against Leishmania major in a CBA mouse model of infection: role of adjuvants and mechanism of protection

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808651

Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808651

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808651

Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis.

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808651

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808651

Natural and acquired resistance to Leishmania: cellular activation by Leishmania aethiopica of mononuclear cells from unexposed individuals is through the stimulation of natural killer (NK) cells.

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808651

Ly-49A, a receptor for H-2Dd, has a functional carbohydrate recognition domain

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808651

Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection.

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808651

Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808651

Contribution of non-Leishmania-specific immunity to resistance to Leishmania infection in humans

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808651

Evidence for Involvement of β-Glucan-Binding Cell Surface Lectins in Human Natural Killer Cell Function

1 October 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02096.X

Differential induction of cellular responses by live and dead Leishmania promastigotes in healthy donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02096.X

ALeishmaniaHomologue of Receptors for Activated C‐Kinase (LACK) Induces Both Interferon‐γ and Interleukin‐10 in Natural Killer Cells of Healthy Blood Donors

21 January 2018

2 references

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02096.X

21 January 2018

12 December 2020

Cells from healthy non-exposed individuals produce cytokines to selected fractions of Leishmania promastigotes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808651

Identification of distinct lymphocyte subsets responding to subcellular fractions of Mycobacterium bovis bacille calmette-Guérin (BCG)

2 December 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02096.X

IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis

21 January 2018

1 reference

12 December 2020

Effectiveness of leishmanization in the control of cutaneous leishmaniasis

1 reference

12 December 2020

Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis

1 reference

12 December 2020

Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes

1 reference

12 December 2020

Field trial of a vaccine against New World cutaneous leishmaniasis in an at-risk child population: safety, immunogenicity, and efficacy during the first 12 months of follow-up

1 reference

12 December 2020

10.1046/J.1365-2249.2003.02096.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605699%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

PMC publication ID

1808651

0 references

1 reference